$375+ Billion Drug Delivery Devices Markets - Global Industry Size, Share, Trends, Opportunity, and Forecasts, 2019-2023 and 2024-2029F
08 mai 2024 09h01 HE
|
Research and Markets
Dublin, May 08, 2024 (GLOBE NEWSWIRE) -- The "Drug Delivery Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ...
Drug Delivery Collaboration, Development, Research and Licensing Deals Analysis Report 2024 with Directory of 1,666 Agreements Signed Since 2019
07 mai 2024 06h33 HE
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Drug Delivery Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Drug Delivery Collaboration and...
Drug Delivery Technologies Market Report 2024-2034 - Sustainable and Eco-friendly Innovations in Drug Delivery Technologies
06 mai 2024 04h31 HE
|
Research and Markets
Dublin, May 06, 2024 (GLOBE NEWSWIRE) -- The "Drug Delivery Technologies Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for Drug Delivery Technologies...
Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman
17 avr. 2024 16h05 HE
|
Serina Therapeutics, Inc.
- Dr. Gill brings extensive leadership experience in transformative biotechnology platforms and drug development - HUNTSVILLE, AL, April 17, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (NYSE...
Cingulate to Participate in Planet MicroCap Showcase: Vegas 2024
16 avr. 2024 17h00 HE
|
Cingulate Inc.
KANSAS CITY, Kan., April 16, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Cingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update
01 avr. 2024 08h00 HE
|
Cingulate Inc.
$17.8 Million Raised Since Beginning of 2023$9.1 Million of Debt Converted to Equity at a PremiumPhase 3 ADHD Data Continues to Impress KANSAS CITY, Kan., April 01, 2024 (GLOBE NEWSWIRE) --...
Cingulate to Participate in Benzinga All Live Access Event
19 mars 2024 16h45 HE
|
Cingulate Inc.
KANSAS CITY, Kan., March 19, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Long-Acting Drug Delivery Technologies and Services Market Predicted to Reach $36.82 Billion by 2033, as Asia-Pacific Emerges with Highest CAGR
28 févr. 2024 09h56 HE
|
Research and Markets
Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "Long-Acting Drug Delivery Technologies and Services Market: A Global and Regional Analysis, 2023-2033" report has been added to ...
Global Advanced Drug Delivery Systems Markets and Technologies Report 2024, with Compound Annual Growth Projections Through 2028
19 févr. 2024 04h29 HE
|
Research and Markets
Dublin, Feb. 19, 2024 (GLOBE NEWSWIRE) -- The "Global Markets and Technologies for Advanced Drug Delivery Systems" report has been added to ResearchAndMarkets.com's offering. The global market...
Werth Family Investment Associates Converts Remaining $3.3M of Debt and Accrued Interest into Cingulate Equity at Premium to Market
29 janv. 2024 06h45 HE
|
Cingulate Inc.
KANSAS CITY, Kan., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) (Cingulate), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery...